Fulltext

Development of a monitoring system for heroin-assisted substitution treatment in Switzerland

Gschwend, Patrick ; Rehm, Jürgen ; Lezzi, Stefan ; Blättler, Richard ; Steffen, Thomas ; Gutzwiller, Felix ; Uchtenhagen, Ambros

In: Sozial- und Präventivmedizin, 2002, vol. 47, no. 1, p. 33-38

Zum persönliche Liste hinzufügen
    Titel
    • Development of a monitoring system for heroin-assisted substitution treatment in Switzerland
    Autor
    • Gschwend, Patrick. Addiction Research Institute, Konradstrasse 32, P.O. Box, CH-8031, Zurich
    • Rehm, Jürgen. Addiction Research Institute, Konradstrasse 32, P.O. Box, CH-8031, Zurich
    • Lezzi, Stefan. Addiction Research Institute, Konradstrasse 32, P.O. Box, CH-8031, Zurich
    • Blättler, Richard. Addiction Research Institute, Konradstrasse 32, P.O. Box, CH-8031, Zurich
    • Steffen, Thomas. Addiction Research Institute, Konradstrasse 32, P.O. Box, CH-8031, Zurich
    • Gutzwiller, Felix. Institute for Social and Preventive Medicine, Konradstrasse 32, P.O. Box, CH-8031, Zurich
    • Uchtenhagen, Ambros. Addiction Research Institute, Konradstrasse 32, P.O. Box, CH-8031, Zurich
    Dokumententyp
    • Postprint
    Sprache
    • Englisch
    Veröffentlicht in
    • Sozial- und Präventivmedizin, 2002, vol. 47, no. 1, p. 33-38. Birkhäuser-Verlag
    Andere elektronische Ausgabe
    OAI-PMH-ID
    • oai:doc.rero.ch:320946
    Summary
    Summary: Objectives: Switzerland introduced heroin-assisted treatment as a routine treatment for drug addicts. As a result the evaluation instruments were changed from a detailed scientific project to a routine monitoring system. The process for developing this monitoring system is described. Methods: The questionnaires and assessment instruments were restyled with staff of the treatment agencies. Indicators measuring quality of treatment and measures from the future national statistic on the addiction support system were integrated into admission, course and discharge questionnaires. Currently a system for feedback to treatment agencies is being developed. Results: All 21 treatment agencies are participating in the monitoring. Assessment quality is high. Conclusions: The described monitoring should provide continuous delivery of basic relevant data on patients